Kampmann Lab featured in Vox article on CRISPR uses

The Kampmann Lab's approach of using CRISPR to identify relevant genes, mechanisms, and therapeutic targets in neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease was featured today in a front page article on Vox. The article presented 7 innovative ways in which CRISPR technology will make an impact in 2017.

http://www.vox.com/science-and-health/2017/1/3/14093794/crispr-gene-editing-designer-babies